Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AIN | US
1.08
1.16%
Consumer Cyclical
Textile Manufacturing
30/06/2024
30/08/2024
94.16
92.83
94.20
92.47
Albany International Corp. together with its subsidiaries engages in the textile and materials processing business. The company operates in two segments Machine Clothing (MC) and Albany Engineered Composites (AEC). The MC segment designs manufactures and markets paper machine clothing for use in the manufacturing of papers paperboards tissues towels nonwovens building products tannery and textiles. This segment offers forming pressing and drying fabrics as well as process belts; and engineered fabrics. The AEC segment 3D-woven and injected composite components for aircraft engines composite airframe and engine components for military and commercial aircraft. It operates in the United States Switzerland Brazil China France Mexico Italy and internationally. The company was incorporated in 1895 and is headquartered in Rochester New Hampshire.
View LessPositive Momentum
Low 6-Month Volatility (<30%)
Strong Revenue Growth (> 10%)
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
14.9%1 month
28.2%3 months
27.0%6 months
27.8%26.90
-
3.01
0.39
0.22
11.88
2.54
2.00
265.62M
2.94B
2.94B
1.10
13.51
-7.30
21.10
11.62
2.21
1.45
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
6.52
Range1M
14.10
Range3M
14.22
Rel. volume
0.73
Price X volume
9.56M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Amneal Pharmaceuticals Inc | AMRX | Drug Manufacturers-Specialty & Generic | 8.66 | 2.64B | -0.12% | n/a | -4430.76% |
Catalyst Pharmaceuticals Inc | CPRX | Drug Manufacturers-Specialty & Generic | 20.25 | 2.40B | 1.35% | 36.16 | 0.55% |
Amphastar Pharmaceuticals Inc | AMPH | Drug Manufacturers-Specialty & Generic | 48.74 | 2.39B | -0.25% | 15.47 | 87.00% |
Bausch Health Companies Inc | BHC | Drug Manufacturers-Specialty & Generic | 5.93 | 2.18B | 1.02% | n/a | 0.00% |
Patterson Companies Inc | PDCO | Medical Distribution | 22.49 | 1.98B | 0.11% | 12.43 | 94.43% |
PAR Technology Corporation | PAR | Drug Manufacturers-Specialty & Generic | 53.99 | 1.96B | 0.11% | n/a | 65.19% |
Supernus Pharmaceuticals Inc | SUPN | Drug Manufacturers-Specialty & Generic | 35.16 | 1.94B | 0.46% | 390.67 | 4.18% |
Alignment Healthcare Inc. Common Stock | ALHC | Healthcare Plans | 9.01 | 1.72B | 1.35% | n/a | 177.78% |
Tilray Inc | TLRY | Drug Manufacturers-Specialty & Generic | 1.71 | 1.44B | 0.59% | n/a | 0.00% |
Harrow Health Inc | HROW | Drug Manufacturers-Specialty & Generic | 40.46 | 1.44B | 3.06% | n/a | 331.16% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 11.88 | - | - |
Ent. to Revenue | 2.54 | - | - |
PE Ratio | 26.90 | - | - |
Price to Book | 3.01 | - | - |
Dividend Yield | 1.10 | - | - |
Std. Deviation (3M) | 26.96 | - | - |
Debt to Equity | 0.39 | - | - |
Debt to Assets | 0.22 | - | - |
Market Cap | 2.94B | - | - |